Patent · US Active

Tenofovir alafenamide hemifumarate

US8754065B2 · kind B2 · utility

36Cited by
4References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2012
Grant dateJun 17, 2014
Priority date—
Expiry dateAug 15, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.